Evolution in the risk of adverse events of adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer

被引：0
|
作者：
Daniel Reinhorn
Rinat Yerushalmi
Assaf Moore
Alexandra Desnoyers
Ramy R. Saleh
Eitan Amir
Hadar Goldvaser
机构：
[1] Beilinson Hospital,Davidoff Cancer Center, Rabin Medical Center
[2] Tel Aviv University,Sackler Faculty of Medicine
[3] University of Toronto and Princess Margaret Cancer Centre,Division of Medical Oncology
来源：
Breast Cancer Research and Treatment | 2020年 / 182卷
关键词：
Breast cancer; Adjuvant; Tamoxifen; Aromatase inhibitors; Toxicity; Adverse events;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：259 / 266
页数：7
相关论文
共 50 条
  • [1] Evolution in the risk of adverse events of adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer
    Reinhorn, D. J.
    Amir, E.
    Yerushalmi, R.
    Goldvaser, H.
    ANNALS OF ONCOLOGY, 2019, 30
  • [2] Evolution in the risk of adverse events of adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer
    Reinhorn, Daniel
    Yerushalmi, Rinat
    Moore, Assaf
    Desnoyers, Alexandra
    Saleh, Ramy R.
    Amir, Eitan
    Goldvaser, Hadar
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 182 (02) : 259 - 266
  • [3] Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: A decision analysis
    Punglia, RS
    Kuntz, KM
    Winer, EP
    Weeks, JC
    Burstein, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) : 5178 - 5187
  • [4] THE RISK OF ISCHEMIC HEART DISEASE WITH ADJUVANT ENDOCRINE THERAPY IN POSTMENOPAUSAL WOMEN WITH EARLY STAGE BREAST CANCER
    Abdel-Qadir, H.
    Fischer, H.
    Fu, L.
    Amir, E.
    Harvey, P.
    Lee, D. S.
    Rochon, P.
    Anderson, G.
    CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (10) : S348 - S348
  • [5] Adjuvant endocrine therapy for postmenopausal women with early breast cancer
    Ingle, JN
    CLINICAL CANCER RESEARCH, 2006, 12 (03) : 1031S - 1036S
  • [6] Role of adjuvant endocrine therapy in early-stage breast cancer
    Muss, HB
    SEMINARS IN ONCOLOGY, 2001, 28 (04) : 313 - 321
  • [7] Aromatase inhibitors: A new reality for the adjuvant endocrine treatment of early-stage breast cancer in postmenopausal women
    Colozza, M.
    Califano, R.
    Minenza, E.
    Dinh, P.
    Azambuja, E.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2008, 8 (06) : 564 - 574
  • [8] Selection of optimal adjuvant endocrine therapy for early-stage breast cancer
    Al-Hajj A.
    O'Regan R.
    Current Treatment Options in Oncology, 2006, 7 (2) : 153 - 165
  • [9] Treatment With Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: Is It Forever?
    Overmoyer, Beth
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (08) : 823 - +
  • [10] Does adjuvant therapy with letrozole improve survival in postmenopausal women with early-stage breast cancer?
    Lonning, Per E.
    Geisler, Juergen
    NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (07): : 356 - 357
12345